KCTD8 Antikörper (C-Term)
Kurzübersicht für KCTD8 Antikörper (C-Term) (ABIN953023)
Target
Alle KCTD8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 441-470, C-Term
-
Spezifität
- This antibody recognizes Human KCTD8 (C-term).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 441-470 amino acids from the C-terminal region of human KCTD8
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- KCTD8 (Potassium Channel Tetramerisation Domain Containing 8 (KCTD8))
-
Andere Bezeichnung
- KCTD8
-
Hintergrund
- Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity).Synonyms: BTB/POZ domain-containing protein KCTD8
-
Molekulargewicht
- 52440 Da
-
Gen-ID
- 386617
-
NCBI Accession
- NP_938167
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-